Home / Inspections / 1255610

FDA Inspection 1255610 — Temmler Pharma GmbH & Co. KG

Temmler Pharma GmbH & Co. KG — FEI 3002808339

The FDA completed an inspection of Temmler Pharma GmbH & Co. KG on July 13, 2022 in Marburg. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 13, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Marburg (Germany)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1178993 (VAI Wed Sep 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 953823 (VAI Fri Dec 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 884796 (VAI Thu Jun 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 788609 (VAI Fri Jun 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 668329 (VAI Thu May 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources